Dr Reddy's launch Omeprazole and Sodium bicarbonate capsules in US

Dr Reddy's Laboratories announced that it has launched Omeprazole and Sodium bicarbonate capsules, 20mg/1100mg and 40mg/1100mg, a therapeutic equivalent generic version of Zegerid (omeprazole/sodium bicarbonate) capsules in the United States market, having been approved by the US Food & Drug Administration (USFDA).

The Zegerid brand and generic had US sales of approximately $306.7 million MAT for the most recent twelve months ending in May 2016 according to IMS Health.

Dr Reddy's Omeprazole and sodium bicarbonate capsules 20 mg/1100 mg and 40 mg/1100 mg are available in bottle count size of 30.

Zegerid is a registered trademark of Santarus, Inc. a wholly owned subsidiary of Salix Pharmaceuticals.